Search clinical trials for: NEUPRO

Total 83 results

IRCCS Policlinico S. Matteo
Federico II University; University of Roma La Sapienza

Recruiting

Effect of Fixed Combination Citicoline Homotaurine and Pyrroloquinoline Quinone on Pattern-electroretinogram in Glaucoma

Glaucoma | Neuroprotection

Italy
Virginia Commonwealth University
National Institute on Drug Abuse (NIDA)

Recruiting

Transdermal Rotigotine as Adjunct to Behavioral Therapy for Cocaine Use Disorder

Substance-Related Disorders

United States
Nutricia Research

Not yet recruiting

Bioequivalence of a Diabetes Specific Tube Feed (EQUIDIA)

Postprandial Glucose Response
Royal Devon and Exeter NHS Foundation Trust
University of Plymouth; Plymouth Marjon University

Recruiting

Adapting Body Reprogramming for Severe Asthma: a Feasibility Study (BoBSA)

Severe Asthma

United Kingdom
Peking University Third Hospital

Recruiting

The Practical Effect of Neupro

Parkinson's Disease

China
PARZIBUT Gilles

Not yet recruiting

Non-inferiority Evaluation of Trimbow in Critically Ill Patients Admitted in ICU Compared to Standard of Care (TRIMICU)

COPD Exacerbation
Allina Health System

Recruiting

Multi-lead ECG to Effectively Optimize Resynchronization Devices: New CRT Recipients (METEOR-CRT)

Heart Failure, Systolic

United States
UCB Biopharma SRL

Terminated

A Follow-up Study of Rotigotine Patch in Adolescent Subjects With Restless Legs Syndrome

Restless Legs Syndrome

United States
UCB Biopharma SRL

Terminated

A Study of Rotigotine Patch in Adolescent Subjects With Restless Legs Syndrome of Unknown Cause

Restless Legs Syndrome

United States
Massachusetts General Hospital

Withdrawn

Butrans for Treatment of Restless Legs Syndrome (Butrans)

Restless Legs Syndrome

United States
University Hospital Ostrava

Completed

Cardiac Strains for Optimization of CRT in Non-Responders

Chronic Heart Failure

Czechia
University of Florida

Active, not recruiting

Hydrogen Peroxide to the Wound Following Surgical Incision Affecting Cultures in Primary Shoulder Arthroplast

Primary Anatomic or Reverse Total Shoulder Arthroplasty

United States
I.R.C.C.S. Fondazione Santa Lucia
Alzheimer's Drug Discovery Foundation

Active, not recruiting

Dopaminergic Therapy for Frontotemporal Dementia Patients

Mental Disorders | Brain Diseases | Central Nervous System Diseases | Nervous System Diseases | Neurologic Manifestations | Neurobehavioral Manifestations | Neurocognitive Disorders | Neurodegenerative Diseases | TDP-43 Proteinopathies | Proteostasis Deficiencies | Dementia | Language Disorders | Communication... and other conditions

Italy
Chiesi Farmaceutici S.p.A.

Terminated

Lung Deposition of TRIMBOW® pMDI in Healthy Volunteers, Asthmatic and COPD Patients (STORM)

Chronic Obstructive Pulmonary Disease | Asthma

United Kingdom
IRCCS Policlinico S. Matteo

Terminated

Effect of Citicoline/Homotaurine on PERG in Primary Open Angle Glaucoma

Glaucoma

Italy
Luye Pharma Group Ltd.

Completed

A Study to Assess Pharmacokinetic Profiles of LY03003 and Neupro

Parkinson Disease

United States
Göteborg University
Vastra Gotaland Region

Completed

Optimization of Cochlear Implant MAP-parameters in Children

Child | Deafness | Cochlear Implants | Hearing | Evoked Potentials, Auditory | Disabilities Hearing

Sweden
Sandoz

Terminated

An Open, Randomised, Single Dose, 2-period, 2-sequence Crossover Adhesion Study of Two Different Transdermal Patches Containing Rotigotine.

Parkinson Disease

Germany
Luye Pharma Group Ltd.

Completed

A Randomized, Open-Label, Crossover Study to Evaluate the Pharmacokinetic Profiles of Rotigotine After a Single Dose of LY03003 (28 mg) Versus After a Week of Daily NEUPRO® Transdermal Patch (4 mg Every 24 Hours) in Healthy Volunteers

Parkinson Disease

United States
Johns Hopkins University
National Institute on Aging (NIA)

Terminated

Anxiety in Parkinson's: Use of Quantitative Methods to Guide Rational Treatment (ANXPD)

Parkinson Disease | Anxiety Disorders

United States
Claudia Spies

Completed

Neuroprotection With Dexmedetomidine in Patients Undergoing Elective Cardiac or Abdominal Surgery (Neuprodex)

Delirium | Postoperative Cognitive Deficit (POCD)

Germany
Abbott Medical Devices
Medizinische Einrichtungen der Universität Düsseldorf; Klinikum Duisburg GmbH; NKO Sint-Augustinus Antwerpen

Completed

Burst Optimized Stimulation Study (BOSS)

Chronic Pain

Belgium, Germany
UCB Biopharma S.P.R.L.

Completed

Study to Evaluate the Impact of Using Wearable Devices in Addition to Standard Clinical Practice on Parkinson´s Subject Symptoms Management

Parkinson´s Disease

United States
UCB BIOSCIENCES GmbH

Completed

Trial to Evaluate The Efficacy Of Rotigotine on Parkinson's Disease-Associated Motor Symptoms And Apathy (BRIGHT)

Idiopathic Parkinson's Disease

United States, Austria, Hungary, Poland, Slovakia, Slovenia, Spain
UCB Pharma

Completed

Transdermal Rotigotine User Surveillance Study (TRUST)

Idiopathic Parkinson Disease

Czechia, Denmark, Germany, Greece, Italy, Mexico, Romania, Slovakia, Spain, Switzerland
Arun Rao
Medtronic

Completed

A Comparison of Rate Response Performance in Pacemaker Patients With an Indication of Sinus Node Dysfunction (CRIPS)

Sinus Node Dysfunction

United States
UCB Pharma GmbH

Completed

Observational Study With Neupro® to Evaluate the Patient´s Perception of Pain Associated With Parkinson´s Disease (NEUPAD)

Idiopathic Parkinson's Disease

Germany, Austria
UCB Pharma
UCB Trading (Shanghai) Co. Ltd.

Completed

Rotigotine Versus Placebo, A Study To Evaluate The Efficacy In Advanced Stage Idiopathic Parkinson's Disease Patients

Idiopathic Parkinson's Disease

China
UCB Pharma

Completed

Effect on RLS Symptom Severity After Switching to Neupro® in Patients Who Previously Experienced Augmentation (AURORA)

Restless Legs Syndrome

Germany
University Hospital, Grenoble

Unknown

Non Motors Aspects in De Novo Parkinson's Disease (Honeymoon)

Parkinson Disease | Apathy

France
Chulalongkorn University
Abbott

Unknown

Rotigotine Effect on Nocturnal Hypokinesia Compares to Placebo Control: A Quantitative Assessment by Wearable Sensors

Nocturnal Hypokinesia
Luye Pharma Group Ltd.

Completed

Pharmacokinetic Profile of Neupro Patch Administrated at 2 mg, 4 mg, 6 mg and 8 mg/Day Weekly in Patients With Early-stage Parkinson's Disease

Parkinson's Disease

United States
John Winkelman, MD, PhD
UCB Pharma

Completed

Switching From Oral Dopamine Agonists to Rotigotine (SWITCH)

Restless Legs Syndrome | Ekbom Syndrome | Willis-Ekbom Disease

United States
UCB Biopharma S.P.R.L.
PRA Health Sciences

Completed

Evaluating the Effectiveness of Neupro® (Rotigotine) and L-dopa Combination Therapy in Patients With Parkinson's Disease (NEUPART)

Idiopathic Parkinson's Disease

Germany, France, Italy, Spain, United Kingdom
Inflamax Research Incorporated

Completed

Irritation and Sensitization Potential of Repeat Applications of Rotigotine Patch

Bioequivalence - Irritation and Sensitization Potential of Transdermal Patch

United States, Canada
Azienda Ospedaliera Cardinale G. Panico

Terminated

Possible Use of Rotigotine in Subjects 70 Years and Older With Late Onset of Disease (PARROT)

Parkinson's Disease

Italy
UCB Korea Co., Ltd.

Completed

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Idiopathic Parkinson's Disease

Korea, Republic of
UCB BIOSCIENCES GmbH
Pharmaceutical Health Sciences; Bracket Global

Completed

A Study to Compare the Adhesiveness of 2 Different Rotigotine Patches Used for the Treatment of Parkinson's Disease

Parkinson's Disease

Germany
Luye Pharma Group Ltd.

Completed

Pharmacokinetics and Safety Study of LY03003 in Patients With Early-stage Parkinson's Disease (03003MAD)

Parkinson's Disease

United States
UCB Pharma

Completed

Rotigotine Versus Placebo As Double Blind Study To Evaluate The Efficacy In Early Stage Idiopathic Parkinson's Disease Patients

IDIOPATHIC PARKINSON'S DISEASE

China
East Carolina University

Unknown

Study to Assess Dopamine Receptor Modulation With Rotigotine to Enhance Morphine Analgesia in the Dental Model

Post-op Pain

United States
UCB Pharma

Completed

The Use of Rotigotine for Treatment of Reducing Signs and Symptoms of Fibromyalgia in Adults. (SP888)

Fibromyalgia Syndrome

United States
UCB Pharma

Completed

Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine (RECOVER)

Parkinson's Disease

United States, Poland, United Kingdom, Spain, South Africa, Austria, Germany, Hungary, Italy, New Zealand, Australia, Finland
Rambam Health Care Campus

Unknown

Perioperative Management of Patients With Cardiac Implantable Electronic Devices (MAGNET)

CARDIAC PACEMAKERS DEFIBRILLATOR ELECTROMAGNETIC

Israel
Biologische Heilmittel Heel GmbH

Completed

Explorative Efficacy Profile of Neurexan® in an Experimental Acute Stress Setting in Healthy Subjects (NEUPRO-DB)

Acute Stress Reaction

Germany
Biologische Heilmittel Heel GmbH

Completed

Explorative Open Label Study of Efficacy Profile of Neurexan® in Experimental Acute Stress Setting in Healthy Subjects (NEUPRO-OL)

Acute Stress Reaction

Germany
UCB BIOSCIENCES GmbH

Completed

A Sleep Laboratory Study to Investigate the Safety and Efficacy of the Rotigotine Skin Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis

Restless Legs Syndrome | End-Stage Renal Disease

United States, Austria, Finland, France, Germany, Italy
UCB Pharma

Completed

Trial to Assess Parkinson's Disease (PD) Symptom Control to Four Doses of Rotigotine in a Transdermal Patch

Parkinson's Disease

United States, Chile, Mexico, India, Peru
UCB Pharma

Terminated

Long-term Extension of RECOVER- Long-term Effect of the 24h Transdermal Delivery of Rotigotine in Subjects With Idiopathic Parkinson's Disease

Parkinson's Disease

Spain, South Africa, New Zealand, Hungary, United States, Germany, Italy, Australia, Finland, United Kingdom, Poland
UCB Pharma

Completed

Cardiac Effects of Rotigotine Transdermal System in Subjects With Advanced-stage Idiopathic Parkinson's Disease

Parkinson's Disease

South Africa

Search clinical trials for: NEUPRO

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Myanmar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations